Daniela Cota - Publications

Affiliations: 
INSERM, Rennes, Bretagne, France 
Area:
Energy Balance, Neuroendocrinology

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, Obici S, Sandoval DA. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy. Annals of Surgery. PMID 30702457 DOI: 10.1097/SLA.0000000000003093  0.56
2017 Quarta C, Clemmensen C, Zhu Z, Yang B, Joseph SS, Lutter D, Yi CX, Graf E, García-Cáceres C, Legutko B, Fischer K, Brommage R, Zizzari P, Franklin BS, Krueger M, ... ... Cota D, et al. Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity. Cell Metabolism. PMID 28943448 DOI: 10.1016/j.cmet.2017.08.023  1
2015 Bermudez-Silva FJ, Romero-Zerbo SY, Haissaguerre M, Ruz-Maldonado I, Lhamyani S, El Bekay R, Tabarin A, Marsicano G, Cota D. Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis. Disease Models & Mechanisms. PMID 26563389 DOI: 10.1242/dmm.020750  1
2015 Mazier W, Saucisse N, Gatta-Cherifi B, Cota D. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease. Trends in Endocrinology and Metabolism: Tem. 26: 524-37. PMID 26412154 DOI: 10.1016/j.tem.2015.07.007  1
2015 Gatta-Cherifi B, Cota D. Endocannabinoids and Metabolic Disorders. Handbook of Experimental Pharmacology. 231: 367-91. PMID 26408168 DOI: 10.1007/978-3-319-20825-1_13  1
2015 Gatta-Cherifi B, Cota D. New insights on the role of the endocannabinoid system in the regulation of energy balance. International Journal of Obesity (2005). PMID 26374449 DOI: 10.1038/ijo.2015.179  1
2015 Cardinal P, Bellocchio L, Guzmán-Quevedo O, André C, Clark S, Elie M, Leste-Lasserre T, Gonzales D, Cannich A, Marsicano G, Cota D. Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice. Endocrinology. 156: 411-8. PMID 25456065 DOI: 10.1210/en.2014-1437  1
2015 Lu B, Diz-Chaves Y, Markovic D, Contarino A, Penicaud L, Fanelli F, Clark S, Lehnert H, Cota D, Grammatopoulos DK, Tabarin A. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms. International Journal of Obesity (2005). 39: 408-17. PMID 25189177 DOI: 10.1038/ijo.2014.164  1
2014 Cardinal P, André C, Quarta C, Bellocchio L, Clark S, Elie M, Leste-Lasserre T, Maitre M, Gonzales D, Cannich A, Pagotto U, Marsicano G, Cota D. CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin. Molecular Metabolism. 3: 705-16. PMID 25352999 DOI: 10.1016/j.molmet.2014.07.004  1
2014 Haissaguerre M, Saucisse N, Cota D. Influence of mTOR in energy and metabolic homeostasis. Molecular and Cellular Endocrinology. 397: 67-77. PMID 25109278 DOI: 10.1016/j.mce.2014.07.015  1
2014 Cota D. mTORC2, the "other" mTOR, is a new player in energy balance regulation. Molecular Metabolism. 3: 349-50. PMID 24944894 DOI: 10.1016/j.molmet.2014.04.002  1
2014 Soria-Gómez E, Massa F, Bellocchio L, Rueda-Orozco PE, Ciofi P, Cota D, Oliet SH, Prospéro-García O, Marsicano G. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake. Neuroscience. 263: 46-53. PMID 24434770 DOI: 10.1016/j.neuroscience.2014.01.005  1
2014 Binder E, Bermúdez-Silva FJ, Elie M, Leste-Lasserre T, Belluomo I, Clark S, Duchampt A, Mithieux G, Cota D. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice. Obesity (Silver Spring, Md.). 22: 713-20. PMID 23894080 DOI: 10.1002/oby.20578  1
2013 Bosier B, Bellocchio L, Metna-Laurent M, Soria-Gomez E, Matias I, Hebert-Chatelain E, Cannich A, Maitre M, Leste-Lasserre T, Cardinal P, Mendizabal-Zubiaga J, Canduela MJ, Reguero L, Hermans E, Grandes P, ... Cota D, et al. Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Molecular Metabolism. 2: 393-404. PMID 24327955 DOI: 10.1016/j.molmet.2013.08.001  1
2013 Binder E, Bermúdez-Silva FJ, André C, Elie M, Romero-Zerbo SY, Leste-Lasserre T, Belluomo I, Duchampt A, Clark S, Aubert A, Mezzullo M, Fanelli F, Pagotto U, Layé S, Mithieux G, ... Cota D, et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. Plos One. 8: e74705. PMID 24086364 DOI: 10.1371/journal.pone.0074705  1
2013 Bellocchio L, Soria-Gómez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Häring M, Martín-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, ... ... Cota D, et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade. Proceedings of the National Academy of Sciences of the United States of America. 110: 4786-91. PMID 23487769 DOI: 10.1073/pnas.1218573110  1
2012 André C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. The Proceedings of the Nutrition Society. 71: 502-10. PMID 22877732 DOI: 10.1017/S0029665112000754  1
2012 Matias I, Gatta-Cherifi B, Tabarin A, Clark S, Leste-Lasserre T, Marsicano G, Piazza PV, Cota D. Endocannabinoids measurement in human saliva as potential biomarker of obesity. Plos One. 7: e42399. PMID 22860123 DOI: 10.1371/journal.pone.0042399  1
2012 Cardinal P, Bellocchio L, Clark S, Cannich A, Klugmann M, Lutz B, Marsicano G, Cota D. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology. 153: 4136-43. PMID 22778221 DOI: 10.1210/en.2012-1405  1
2012 Gatta-Cherifi B, Matias I, Vallée M, Tabarin A, Marsicano G, Piazza PV, Cota D. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. International Journal of Obesity (2005). 36: 880-5. PMID 21844878 DOI: 10.1038/ijo.2011.165  1
2012 Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology (Oxford, England). 26: 114-24. PMID 21824982 DOI: 10.1177/0269881111408458  1
2011 Bajzer M, Olivieri M, Haas MK, Pfluger PT, Magrisso IJ, Foster MT, Tschöp MH, Krawczewski-Carhuatanta KA, Cota D, Obici S. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia. 54: 3121-31. PMID 21987346 DOI: 10.1007/s00125-011-2302-6  1
2011 Cota D, Marsicano G. New fat and new neurons: endocannabinoids control neurogenesis in obesity (Commentary on Rivera et al.). The European Journal of Neuroscience. 33: 1575-6. PMID 21535244 DOI: 10.1111/j.1460-9568.2011.07684.x  1
2011 Catania C, Binder E, Cota D. mTORC1 signaling in energy balance and metabolic disease. International Journal of Obesity (2005). 35: 751-61. PMID 20877289 DOI: 10.1038/ijo.2010.208  1
2010 Quarta C, Bellocchio L, Mancini G, Mazza R, Cervino C, Braulke LJ, Fekete C, Latorre R, Nanni C, Bucci M, Clemens LE, Heldmaier G, Watanabe M, Leste-Lassere T, Maitre M, ... ... Cota D, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism. 11: 273-85. PMID 20374960 DOI: 10.1016/j.cmet.2010.02.015  1
2010 Bellocchio L, Lafenêtre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nature Neuroscience. 13: 281-3. PMID 20139974 DOI: 10.1038/nn.2494  1
2009 Villanueva EC, Münzberg H, Cota D, Leshan RL, Kopp K, Ishida-Takahashi R, Jones JC, Fingar DC, Seeley RJ, Myers MG. Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. Endocrinology. 150: 4541-51. PMID 19628573 DOI: 10.1210/en.2009-0642  1
2009 Cota D, Sandoval DA, Olivieri M, Prodi E, D'Alessio DA, Woods SC, Seeley RJ, Obici S. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism. Obesity (Silver Spring, Md.). 17: 1641-5. PMID 19325539 DOI: 10.1038/oby.2009.84  1
2009 Cota D. Mammalian target of rapamycin complex 1 (mTORC1) signaling in energy balance and obesity. Physiology & Behavior. 97: 520-4. PMID 19296907 DOI: 10.1016/j.physbeh.2009.03.006  1
2008 Proulx K, Cota D, Woods SC, Seeley RJ. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system. Diabetes. 57: 3231-8. PMID 18776140 DOI: 10.2337/db07-1690  1
2008 Cota D, Matter EK, Woods SC, Seeley RJ. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7202-8. PMID 18614690 DOI: 10.1523/JNEUROSCI.1389-08.2008  1
2008 Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annual Review of Nutrition. 28: 295-311. PMID 18429698 DOI: 10.1146/annurev.nutr.28.061807.155505  1
2008 Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. Journal of Neuroendocrinology. 20: 35-8. PMID 18426497 DOI: 10.1111/j.1365-2826.2008.01673.x  1
2008 Cota D. Role of the endocannabinoid system in energy balance regulation and obesity. Frontiers of Hormone Research. 36: 135-45. PMID 18230900 DOI: 10.1159/0000115362  1
2008 Sandoval D, Cota D, Seeley RJ. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annual Review of Physiology. 70: 513-35. PMID 17988209 DOI: 10.1146/annurev.physiol.70.120806.095256  1
2007 Cota D. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes/Metabolism Research and Reviews. 23: 507-17. PMID 17683024 DOI: 10.1002/dmrr.764  1
2007 Cota D, Proulx K, Seeley RJ. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology. 132: 2158-68. PMID 17498509 DOI: 10.1053/j.gastro.2007.03.049  1
2007 Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 148: 1574-81. PMID 17194743 DOI: 10.1210/en.2005-1649  1
2006 Cota D, Barrera JG, Seeley RJ. Leptin in energy balance and reward: two faces of the same coin? Neuron. 51: 678-80. PMID 16982412 DOI: 10.1016/j.neuron.2006.09.009  1
2006 Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ. Hypothalamic mTOR signaling regulates food intake. Science (New York, N.Y.). 312: 927-30. PMID 16690869 DOI: 10.1126/science.1124147  1
2006 Cota D, Tschöp MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Research Reviews. 51: 85-107. PMID 16364446 DOI: 10.1016/j.brainresrev.2005.10.004  1
2006 Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews. 27: 73-100. PMID 16306385 DOI: 10.1210/er.2005-0009  1
2006 Tangalos EG, Cota D, Fujioka K. Complex Cardiometabolic Risk Factors: Impact, Assessment, and Emerging Therapies Journal of the American Medical Directors Association. 7: 1-10. DOI: 10.1016/j.jamda.2006.06.003  1
2006 Cota D, Proulx K, Woods SC, Seeley RJ. Response [5] Science. 313: 1236+1238.  1
2005 Proulx K, Cota D, Castañeda TR, Tschöp MH, D'Alessio DA, Tso P, Woods SC, Seeley RJ. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 289: R729-37. PMID 15879057 DOI: 10.1152/ajpregu.00029.2005  1
2005 Cota D, Woods SC. The role of the endocannabinoid system in the regulation of energy homeostasis Current Opinion in Endocrinology and Diabetes. 12: 338-351. DOI: 10.1097/01.med.0000178715.87999.69  1
2003 Cota D, Genghini S, Pasquali R, Pagotto U. Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity. Journal of Endocrinological Investigation. 26: 1041-4. PMID 14759080  1
2003 Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation. 112: 423-31. PMID 12897210 DOI: 10.1172/JCI17725  1
2003 Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 27: 289-301. PMID 12629555 DOI: 10.1038/sj.ijo.0802250  1
2003 Marsicano G, Cota D, Stalla GK, Pasquali R, Pagotto U, Lutz B. Cannabinoids in energy balance and prospectives in the therapy of obesity Current Medicinal Chemistry - Central Nervous System Agents. 3: 81-87. DOI: 10.2174/1568015033477839  1
2000 Ceroni L, Cota D, Pasquali R. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis]. Minerva Endocrinologica. 25: 47-54. PMID 11189791  1
2000 Cota D, Ceroni L, Pasquali R. [Steroid therapy and adrenal function]. Recenti Progressi in Medicina. 91: 594-600. PMID 11125954  1
Show low-probability matches.